Mediterranean diet and risk for Alzheimer's disease
Top Cited Papers
- 18 April 2006
- journal article
- research article
- Published by Wiley in Annals of Neurology
- Vol. 59 (6) , 912-921
- https://doi.org/10.1002/ana.20854
Abstract
Objective Previous research in Alzheimer's disease (AD) has focused on individual dietary components. There is converging evidence that composite dietary patterns such as the Mediterranean diet (MeDi) is related to lower risk for cardiovascular disease, several forms of cancer, and overall mortality. We sought to investigate the association between MeDi and risk for AD. Methods A total of 2,258 community‐based nondemented individuals in New York were prospectively evaluated every 1.5 years. Adherence to the MeDi (zero‐ to nine‐point scale with higher scores indicating higher adherence) was the main predictor in models that were adjusted for cohort, age, sex, ethnicity, education, apolipoprotein E genotype, caloric intake, smoking, medical comorbidity index, and body mass index. Results There were 262 incident AD cases during the course of 4 (±3.0; range, 0.2–13.9) years of follow‐up. Higher adherence to the MeDi was associated with lower risk for AD (hazard ratio, 0.91; 95% confidence interval, 0.83–0.98; p = 0.015). Compared with subjects in the lowest MeDi tertile, subjects in the middle MeDi tertile had a hazard ratio of 0.85 (95% confidence interval, 0.63–1.16) and those at the highest tertile had a hazard ratio of 0.60 (95% confidence interval, 0.42–0.87) for AD (p for trend = 0.007). Interpretation We conclude that higher adherence to the MeDi is associated with a reduction in risk for AD. Ann Neurol 2006Keywords
This publication has 106 references indexed in Scilit:
- Oncoplastic Breast Surgery for Cancer: Analysis of 540 Consecutive CasesPlastic and Reconstructive Surgery, 2010
- Role of Dynamic Magnetic Resonance Imaging in the Evaluation of Tumor Response to Preoperative Concurrent Radiochemotherapy for Large Breast Cancers: A Prospective Phase II StudyInternational Journal of Radiation Oncology*Biology*Physics, 2007
- Phase III Trial of Concurrent or Sequential Adjuvant Chemoradiotherapy After Conservative Surgery for Early-Stage Breast Cancer: Final Results of the ARCOSEIN TrialJournal of Clinical Oncology, 2007
- The Effect on Tumor Response of Adding Sequential Preoperative Docetaxel to Preoperative Doxorubicin and Cyclophosphamide: Preliminary Results From National Surgical Adjuvant Breast and Bowel Project Protocol B-27Journal of Clinical Oncology, 2003
- Pre-operative chemotherapy and radiotherapy in breast cancerEuropean Journal Of Cancer, 1998
- Neoadjuvant versus adjuvant chemotherapy in premenopausal patients with tumours considered too large for breast conserving surgery: Preliminary results of a randomised trial: S6European Journal Of Cancer, 1994
- The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in OncologyJNCI Journal of the National Cancer Institute, 1993
- A new method of classifying prognostic comorbidity in longitudinal studies: Development and validationJournal of Chronic Diseases, 1987
- Clinical diagnosis of Alzheimer's diseaseNeurology, 1984
- A New Clinical Scale for the Staging of DementiaThe British Journal of Psychiatry, 1982